Japan is hosting the G7 Summit in Hiroshima on May 19–21, 2023. Japan’s presidency comes at a time when the COVID-19 pandemic, the crisis in Ukraine, climate change, and other global events have impacted almost every aspect of society and nature. Prior to the start of Japan’s presidency, JCIE established the Hiroshima G7 Global Health Task Force under its Executive Committee on Global Health and Human Security. The Task Force, a multistakeholder, cross-disciplinary group made up of over 30 domestic members and international advisors, is working to craft recommendations to the Japanese government on the G7 agenda for global health on the major three themes of: 100 Days Mission and Access & Delivery (100 Days Mission PLUS); resilient, equitable, and sustainable Universal Health Coverage (UHC); and global health architecture including sustainable financing.
While crafting these recommendations, the Task Force members convened a series of meetings with various representatives from the G20 Health and Development Partnership, C7, NGOs, the Global South, and global health advocates to discuss the various priorities of the Task Force ahead of the G7 Summit in May.
Dialogue with C7 members
February 10, 2023
Welcoming Remarks
Akio Okawara, President & CEO, Japan Center for International Exchange (JCIE) [moderator]
Meeting Introduction
Masaki Inaba, Task Force member; Domestic Coordinator, C7 2023 Global Health Working Group
Presentation on Draft Recommendations
Hideaki Shiroyama, Task Force Director
Initial Comments from C7 Members
Discussion
- How can G7 promote global efforts to ensure that “no one left is behind” under the goal to attain UHC by engaging CSOs and communities in health system strengthening, and financial resource mobilization for health?
- How can G7 ensure more equitable access to medical countermeasures (MCMs) while increasing incentives for rapid R&D? How can G7 ensure transparency and accountability to the Global South and CSOs throughout the value chains of MCM?
- How can G7 contribute to transforming the global health architecture to adapt to a new normal in terms of norm-setting through the negotiation process of the international legal framework for PPR, institution building, and financial arrangements?
Closing Remarks
Osamu Kunii, Task Force Deputy-Director and 100 Days Mission PLUS Chair
C7 and International CSOs
[On-site]
Stefania Burbo, Focal Point and Advocacy Officer, Global Health Italian Network; International Coordinator, C7 2023 Global Health Working Group
Jennifer Ho, Deputy Director, APCASO (regional civil society network of community-based and non-government organisations on HIV, health, and social justice)
Kaori Horiuchi, Executive Director, Africa-Japan Forum
Sakiko Fukuda Parr, Vice-Chair, UN Committee for Development Policy; Professor of International Affairs, The New School; Chair, Board of Directors, Knowledge Ecology International; Distinguished Fellow, JICA Ogata Sadako Research Institute for Peace and Development
[Online]
Wondu Bekele, Executive Director, Mathiwos Wondu Ethiopian Cancer Society
Kurt Frieder, President, Fundacion Huesped, Argentina
Mohga Kamal-Yanni, Senior policy advisor to UNAIDS and The People Vaccine Alliance; Key advisor to the NGOs representative, UNITAID; Global Health and Access to Medicines Consultant
Smitha Sadasivan, Accessibility Consultant, Election Commission of India; Member, UHC2030 Civil Society Engagement Mechanism (CSEM) Advisory Group
DY Sharya, Founder, Alzheimer’s Indonesia; Regional Director, Alzheimer’s Disease International Asia Pacific
Dialogue on 100-Days Mission PLUS
February 08, 2023
Welcoming Remarks
Representative, Japan Center for International Exchange (JCIE)
Presentation of Recommendations on 100 Days Mission PLUS
Osamu Kunii, 100DM PLUS Working Group Chair
Discussion
Osamu Kunii [moderator]
Closing Remarks
Representative, Japan Center for International Exchange (JCIE)
Guest Speakers (including International Advisors for the Task Force)
Manica Balasegaram, Executive Director, Global Antibiotic Research and Development Partnership (GARDP)
Pascale Boulet, IP & Access Leader, DNDi
Willo Brock, Vice President, External Affairs, FIND
Carmen Pérez Casas, Senior Strategy Advisor, Unitaid
Michelle Childs, Director of Policy Advocacy, DNDi
Thomas B. Cueni, Director General, IFPMA
Philippe Fauchet, Founder, Mirasense Partners; Former President, GlaxoSmithKline Japan
Sakiko Fukuda-Parr, Chair of the Board, Knowledge Ecology International
Charles Gore, Executive Director, Medicines Patent Pool
Béatrice Greco, Director R&D – Access, Global Health Institute, Merck
Richard Hatchett, CEO, CEPI
Piotr Kolczyński, EU Health Policy & Advocacy Advisor, Oxfam and People’s Vaccine Alliance
Cecilia Oh, Programme Advisor, Access and Delivery Partnership, HIV and Health Group, Bangkok Regional Hub, UNDP
Ahmed Ogwell Ouma, Acting Director, Africa CDC
Heulwen Philpot, International Pandemic Preparedness Secretariat
John Reeder, Acting Chief Scientist, WHO
Marie-Ange Saraka-Yao, Managing Director, Resource Mobilisation, Private Sector Partnerships and Innovative Finance, Gavi
Dianne Stewart, Deputy Director of External Relations and Communications Division, the Global Fund
Margo Warren, Head of Government Engagement and Policy, Access to Medicines Foundation
Naoko Yamamoto, Professor, International University of Health and Welfare
Task Force 100 DM PLUS Working Group, Secretariat, and Observers
Keishi Abe, Senior Fellow, GRIPS ALLIANCE, National Graduate Institute for Policy Studies
Sarah Krull Abe, Section Head, Division of Prevention, National Cancer Center Institute for Cancer Control [Scientific Coordinator of the TF]
Masaki Inaba, Co-Chair, Africa Japan Forum; Chair, Japan CSO Network on Global Health
Osamu Kunii, CEO & Executive Director, Global Health Initiative Technology (GHIT) Fund [Chair of the 100DM PLUS WG]
Kaori Nakatani, Japan Director, DNDi
Yoshitaka Nishino, Research Associate, JCIE [Assistant Coordinator of the TF]
Haruka Sakamoto, Associate Professor, Department of International Health and Tropical Diseases, Tokyo Women’s Medical University
Tomoko Suzuki, Chief Program Officer, JCIE [Lead Coordinator of the TF]
Dialogue with Members of Japan CSO Network on Global Health
February 02, 2023
Welcoming Remarks
Asami Kamiya, Japanese Organization for International Cooperation in Family Planning (JOICFP)
Presentation on Task Force Draft Recommendations
Hideaki Shiroyama, Task Force Director [chair]
Comments from Task Force Members
Questions and Comments from NGOs and Response from Task Force
- UHC
World Health Organization (community)
JOICFP (gender)
Japan Health Policy Organization (climate change and UHC, antimicrobial resistance [AMR])
Asian Arsenic Network (noncommunicable diseases [NCDs], food systems)
DNDi/SDGs Promise (neglected tropical diseases [NTDs])
WaterAid (water)
Malaria No More Japan (infectious diseases/malaria)
Stop TB Partnership (infectious diseases/tuberculosis)
- Response from Task Force, Q&A
- Global Health Architecture
Save the Children
- 100 Days Mission
Doctors Without Borders
Japan Council for Africa
- Response from Task Force, Q&A
Closing Remarks
Tomoko Suzuki, Chief Program Officer, JCIE; Task Force Lead Coordinator
Hiroshima G7 Global Health Task Force [in no particular order]
Hideaki Shiroyama, Task Force Director
Chieko Ikeda, Task Force UHC Group chair; Director of International Cooperation Bureau, National Center for Global Health and Medicine
Haruka Sakamoto, UHC/100 Days Mission Plus Group Task Force Member; Associate Professor, Department of International Affairs and Tropical Medicine, Tokyo Women’s University
Shuhei Nomura, UHC Group Task Force member; Project Associate Professor, Department of Health Policy and Management, School of Medicine, Keio University
Tomoko Suzuki, Chief Program Officer, JCIE/Japan
Yoshitaka Nishino, Research Associate, JCIE/Japan
NGO Represtatives [in no particular order]
Tamiko Ishiyama, Director, Asia Arsenic Network
Masaki Inaba, Director or International Health, Africa-Japan Council
Shunsei Koizumi Global Health Project Coordinator, Africa-Japan Council
Kaoru Takahashi, Executive Director, WaterAid Japan
Chine Hayashi, Women’s Association for Better Aging Society
Rieko Suzuki, President, SDGs Promise Japan
Kota Yoshioka, Advisor (in charge of NTDs)/Nagasaki University, SDGs Promise Japan
Toru Oda, Assistant to the President, SDGs Promise Japan
Hisako Endo, Member, International and Development Committee, International Women’s Year Liaison Group
Utako Kanasugi, Advocacy Manager, Médecins Sans Frontières (MSF), Japan
Sara Bechstein, Medical External Affairs Senior Officer, Médecins Sans Frontières (MSF), Japan
Ayako Miyamoto, Deputy Secretary General, Stop TB Partnership Japan
Akiko Mera, Executive Director , Medecins du Monde in Japan
Yumiko Horie, Director of Advocacy, Save the Children Japan
Yuka Shimamura, Global Policy Advocacy Officer, Save the Children Japan
Yoshiteru Horie, President, Association for Aid and Relief Japan
Joji Sugawara, Senior Manager, Health and Global Policy Institute
Kaori Nakatani, Head of Office, Drugs for Neglected Diseases initiative (DNDi) Japan
Midori Morioka, Senior External Relations Officer, DNDi Japan
Fumiharu Ishige, Executive Director, Malaria No More Japan
Yumiko Iizuka, Deputy Secretary General, Malaria No More Japan
Mayumi Katsube, Executive Director, JOICFP
Fumie Saito, Global Advocacy Director, JOICFP
Asami Kamiya, Advocacy Director, JOICFP
Dialogue with Global South
February 02, 2023
Welcoming Remarks
Tomoko Suzuki, Chief Program Officer, Japan Center for International Exchange (JCIE); Task Force Lead Coordinator
Presentation on Task Force Draft Recommendations
Hideaki Shiroyama, Task Force Director [chair]
Initial Comments on Draft recommendations
Discussions
Key questions: What exact actions do you expect G7 2023 to take? What is the most important difference you expect G7 to make after G7 2023 compared to before
Concluding Remarks
Hideaki Shiroyama
Participants
Awa Marie Coll-Seck, Minister of State to the President of the Republic of Senegal
Harjyot Khosa, Senior Technical Advisor, International Planned Parenthood Federation (IPPF)
Julia Kosgei, Policy and Advocacy Advisor, People’s Vaccine Alliance
Rosemary Mburu, Executive Director, WACi Health, Kenya
Khuat Thi Hai Oanh, Executive Director, Center for Supporting Community Development Initiatives, Vietnam
Francis Gervase Omaswa, Executive Director, African Centre for Global Health and Social Transformation
Diah Satyani Saminarsih, Founder and CEO, Center for Indonesia’s Strategic Development Initiatives (CISDI); Former Senior Advisor on Gender and Youth to WHO Director General
Walaiporn Patcharanarumol, Director, Global Health Division, Ministry of Public Health; Secretary General, IHPP Foundation
Task Force members and observers
Sarah Krull Abe, Section Head, Division of Prevention, National Cancer Center Institute for Cancer Control [Scientific Coordinator]
Masaki Inaba, Co-Chair, Africa-Japan Forum; Chair, Japan CSO Network on Global Health
Osamu Kunii, Executive Director and CEO, GHIT Fund [Deputy Director; 100 Days Mission PLUS Chair]
Yoshitaka Nishino, Research Associate, JCIE [Assistant Coordinator]
Haruka Sakamoto, Associate Professor, Department of Hygiene and Public Health, Tokyo Women’s Medical College (listen in)
Hideaki Shiroyama, Professor, Graduate School of Public Policy and Graduate School of Law and Politics, University of Tokyo; Director, Institute for Future Initiatives, University of Tokyo [Director]
Tomoko Suzuki, Chief Program Officer, JCIE [Lead Coordinator]
G20 Health and Development Partnership Meeting on UHC
February 01, 2023
hosted by the G20 Health and Development Partnership
Welcoming Remarks
Alan Donnelly, Chairman, The G20 Health and Development Partnership
Keynote Speakers
Tomoko Suzuki, Chief Program Officer, Japan Center for International Exchange (JCIE); Task Force Lead Coordinator
Overview of the G7Hiroshima Global Health Task Force
Chieko Ikeda, Director General, Bureau of International Health Cooperation, National Centre for Global Health and Medicine (UHC Chair)
Shuhei Nomura, Specially Appointed Associate Professor, Department of Medical Policy and Management, Keio University School of Medicine
UHC Proposals for the G7 Hiroshima Summit
Interventions from Panellists and G20HDP partners
Intervention from the Hiroshima G7 Global Health Task Force international advisors and G20HDP partners
Moderated Q&A
Concluding Remarks
Chieko Ikeda
Closing Remarks
Alan Donnelly
